Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Point72 Asset Management, L.P.'s stake in Syndax Pharmaceuticals, Inc. fell to 2.70% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Point72 Asset Management, L.P.'s stake in Syndax Pharmaceuticals, Inc. fell to 2.70%, 2,307,824 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 2.70%
- Shares
- 2,307,824
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 2.70% | 2,307,824 |
| Point72 Capital Advisors, Inc. | 2.70% | 2,307,824 |
| Steven A. Cohen | 2.70% | 2,307,824 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 18, 2025
- Schedule 13G · Point72 Asset Management, L.P. · Jan 22, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026